Aptose Biosciences Inc. (APTO)

Aptose Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2000
Selling, General & Admin	15.59	14.51	19.46	26.48	10.02	10.37	5.55	6.44	7.99	5.4	Upgrade
Research & Development	36.77	28.09	45.99	29.29	16.84	18.73	6.27	7.83	4.87	2.23	Upgrade
Operating Expenses	52.36	42.6	65.45	55.77	26.86	29.11	11.83	14.27	12.86	7.63	Upgrade
Operating Income	-52.36	-42.6	-65.45	-55.77	-26.86	-29.11	-11.83	-14.27	-12.86	-7.63	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0	0.05	0.03	0.22	Upgrade
Other Expense / Income	-1.15	-0.78	-0.09	-0.53	-0.58	-0.24	-0.18	-0.08	-1.18	-0.06	Upgrade
Pretax Income	-51.21	-41.82	-65.35	-55.24	-26.28	-28.87	-11.64	-14.24	-11.71	-7.79	Upgrade
Net Income	-51.21	-41.82	-65.35	-55.24	-26.28	-28.87	-11.64	-14.24	-11.71	-7.79	Upgrade
Shares Outstanding (Basic)	7	6	6	5	3	2	1	1	1	0	Upgrade
Shares Outstanding (Diluted)	7	6	6	5	3	2	1	1	1	0	Upgrade
Shares Change	9.82%	3.57%	8.86%	63.15%	50.22%	49.65%	75.10%	7.03%	128.26%	48.14%	Upgrade
EPS (Basic)	-7.58	-6.80	-10.95	-10.05	-7.80	-12.90	-7.80	-16.80	-14.70	-22.37	Upgrade
EPS (Diluted)	-7.58	-6.80	-10.95	-10.05	-7.80	-12.90	-7.80	-16.80	-14.70	-22.37	Upgrade
Free Cash Flow	-44.62	-32.35	-43.52	-33.97	-21.66	-23.54	-10.24	-12.39	-10.15	-6.32	Upgrade
Free Cash Flow Per Share	-6.61	-5.26	-7.33	-6.23	-6.48	-10.57	-6.88	-14.59	-12.79	-18.17	Upgrade
EBITDA	-50.74	-41.3	-64.73	-54.62	-25.66	-28.78	-11.56	-14.08	-11.6	-7.56	Upgrade
Depreciation & Amortization	0.47	0.53	0.62	0.61	0.61	0.09	0.08	0.12	0.08	0.02	Upgrade
EBIT	-51.21	-41.82	-65.35	-55.24	-26.28	-28.87	-11.64	-14.19	-11.68	-7.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).